Tatva Chintan Pharma Chem wins export order of USD 35,55,000
05 - May - 2025 12:00 | 10 days ago
Tatva Chintan Pharma Chem has received an export order worth of USD 35,55,000 (approx. Rs 29.95 crore) excluding tax for supply of Specialty Chemicals under Pharma & Agro Intermediates & Speciality Chemicals (PASC) category, to be delivered in November / December 2025 (Q3 FY26).
Tatva Chintan Pharma Chem consolidated net profit declines 89.28% in the March 2025 quarter
03 - May - 2025 12:00 | 12 days ago
Net profit of Tatva Chintan Pharma Chem declined 89.28% to Rs 1.03 crore in the quarter ended March 2025 as against Rs 9.61 crore during the previous quarter ended March 2024. Sales rose 9.76% to Rs 107.86 crore in the quarter ended March 2025 as against Rs 98.27 crore during the previous quarter ended March 2024.
For the full year,net profit declined 81.19% to Rs 5.71 crore in the year ended March 2025 as against Rs 30.35 crore during the previous year ended March 2024. Sales declined 2.74% to Rs 382.71 crore in the year ended March 2025 as against Rs 393.50 crore during the previous year ended March 2024.
Board of Tatva Chintan Pharma Chem recommends Final Dividend
02 - May - 2025 12:00 | 13 days ago
Tatva Chintan Pharma Chem announced that the Board of Directors of the Company at its meeting held on 02 May 2025, has recommended a Final Dividend of Rs.1 per share (i.e.10%), subject to the approval of the shareholders.
Tatva Chintan Pharma Chem consolidated net profit declines 89.28% in the March 2025 quarter
03 - May - 2025 12:00 | 12 days ago
Net profit of Tatva Chintan Pharma Chem declined 89.28% to Rs 1.03 crore in the quarter ended March 2025 as against Rs 9.61 crore during the previous quarter ended March 2024. Sales rose 9.76% to Rs 107.86 crore in the quarter ended March 2025 as against Rs 98.27 crore during the previous quarter ended March 2024.
For the full year,net profit declined 81.19% to Rs 5.71 crore in the year ended March 2025 as against Rs 30.35 crore during the previous year ended March 2024. Sales declined 2.74% to Rs 382.71 crore in the year ended March 2025 as against Rs 393.50 crore during the previous year ended March 2024.
Board of Tatva Chintan Pharma Chem recommends Final Dividend
02 - May - 2025 12:00 | 13 days ago
Tatva Chintan Pharma Chem announced that the Board of Directors of the Company at its meeting held on 02 May 2025, has recommended a Final Dividend of Rs.1 per share (i.e.10%), subject to the approval of the shareholders.
Tatva Chintan Pharma Chem wins export order of USD 35,55,000
05 - May - 2025 12:00 | 10 days ago
Tatva Chintan Pharma Chem has received an export order worth of USD 35,55,000 (approx. Rs 29.95 crore) excluding tax for supply of Specialty Chemicals under Pharma & Agro Intermediates & Speciality Chemicals (PASC) category, to be delivered in November / December 2025 (Q3 FY26).
Tatva Chintan Pharma Chem consolidated net profit declines 89.28% in the March 2025 quarter
03 - May - 2025 12:00 | 12 days ago
Net profit of Tatva Chintan Pharma Chem declined 89.28% to Rs 1.03 crore in the quarter ended March 2025 as against Rs 9.61 crore during the previous quarter ended March 2024. Sales rose 9.76% to Rs 107.86 crore in the quarter ended March 2025 as against Rs 98.27 crore during the previous quarter ended March 2024.
For the full year,net profit declined 81.19% to Rs 5.71 crore in the year ended March 2025 as against Rs 30.35 crore during the previous year ended March 2024. Sales declined 2.74% to Rs 382.71 crore in the year ended March 2025 as against Rs 393.50 crore during the previous year ended March 2024.
Board of Tatva Chintan Pharma Chem recommends Final Dividend
02 - May - 2025 12:00 | 13 days ago
Tatva Chintan Pharma Chem announced that the Board of Directors of the Company at its meeting held on 02 May 2025, has recommended a Final Dividend of Rs.1 per share (i.e.10%), subject to the approval of the shareholders.
Tatva Chintan Pharma Chem wins export order of USD 35,55,000
05 - May - 2025 12:00 | 10 days ago
Tatva Chintan Pharma Chem has received an export order worth of USD 35,55,000 (approx. Rs 29.95 crore) excluding tax for supply of Specialty Chemicals under Pharma & Agro Intermediates & Speciality Chemicals (PASC) category, to be delivered in November / December 2025 (Q3 FY26).
Tatva Chintan Pharma Chem consolidated net profit declines 89.28% in the March 2025 quarter
03 - May - 2025 12:00 | 12 days ago
Net profit of Tatva Chintan Pharma Chem declined 89.28% to Rs 1.03 crore in the quarter ended March 2025 as against Rs 9.61 crore during the previous quarter ended March 2024. Sales rose 9.76% to Rs 107.86 crore in the quarter ended March 2025 as against Rs 98.27 crore during the previous quarter ended March 2024.
For the full year,net profit declined 81.19% to Rs 5.71 crore in the year ended March 2025 as against Rs 30.35 crore during the previous year ended March 2024. Sales declined 2.74% to Rs 382.71 crore in the year ended March 2025 as against Rs 393.50 crore during the previous year ended March 2024.
Board of Tatva Chintan Pharma Chem recommends Final Dividend
02 - May - 2025 12:00 | 13 days ago
Tatva Chintan Pharma Chem announced that the Board of Directors of the Company at its meeting held on 02 May 2025, has recommended a Final Dividend of Rs.1 per share (i.e.10%), subject to the approval of the shareholders.
Tatva Chintan Pharma Chem consolidated net profit declines 89.28% in the March 2025 quarter
03 - May - 2025 12:00 | 12 days ago
Net profit of Tatva Chintan Pharma Chem declined 89.28% to Rs 1.03 crore in the quarter ended March 2025 as against Rs 9.61 crore during the previous quarter ended March 2024. Sales rose 9.76% to Rs 107.86 crore in the quarter ended March 2025 as against Rs 98.27 crore during the previous quarter ended March 2024.
For the full year,net profit declined 81.19% to Rs 5.71 crore in the year ended March 2025 as against Rs 30.35 crore during the previous year ended March 2024. Sales declined 2.74% to Rs 382.71 crore in the year ended March 2025 as against Rs 393.50 crore during the previous year ended March 2024.
Board of Tatva Chintan Pharma Chem recommends Final Dividend
02 - May - 2025 12:00 | 13 days ago
Tatva Chintan Pharma Chem announced that the Board of Directors of the Company at its meeting held on 02 May 2025, has recommended a Final Dividend of Rs.1 per share (i.e.10%), subject to the approval of the shareholders.
